Halozyme Therapeutics, Inc. (HALO)
71.21
-0.61
(-0.85%)
USD |
NASDAQ |
Jan 16, 16:00
71.20
-0.01
(-0.01%)
After-Hours: 20:00
Halozyme Therapeutics Price: 71.21 for Jan. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 218.66 |
| Merck & Co., Inc. | 108.83 |
| AIM ImmunoTech, Inc. | 1.34 |
| Stryker Corp. | 363.78 |
| Skye Bioscience, Inc. | 1.00 |
Price Related Metrics
| PE Ratio | 14.97 |
| PS Ratio | 7.192 |
| PEG Ratio | 0.2607 |
| Price to Book Value | 16.62 |
| Price to Free Cash Flow | 14.84 |
| Earnings Yield | 6.68% |
| Market Cap | 8.374B |
| PEGY Ratio | 0.2607 |
| Operating PE Ratio | 12.12 |
| Normalized PE Ratio | 14.97 |